Annual Long Term Debt
$1.46 M
-$1.04 M-41.70%
December 31, 2024
Summary
- As of March 12, 2025, MLTX annual long term debt is $1.46 million, with the most recent change of -$1.04 million (-41.70%) on December 31, 2024.
- During the last 3 years, MLTX annual long term debt has risen by +$1.46 million (+100.00%).
- MLTX annual long term debt is now -41.70% below its all-time high of $2.50 million, reached on December 31, 2023.
Performance
MLTX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$1.46 M
-$478.10 K-24.70%
December 31, 2024
Summary
- As of March 12, 2025, MLTX quarterly long term debt is $1.46 million, with the most recent change of -$478.10 thousand (-24.70%) on December 31, 2024.
- Over the past year, MLTX quarterly long term debt has dropped by -$478.10 thousand (-24.70%).
- MLTX quarterly long term debt is now -41.70% below its all-time high of $2.50 million, reached on December 31, 2023.
Performance
MLTX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
MLTX Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.7% | -24.7% |
| 3 y3 years | +100.0% | +1500.0% |
| 5 y5 years | +100.0% | +1500.0% |
MLTX Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -41.7% | -100.0% | -41.7% | -100.0% |
| 5 y | 5-year | -41.7% | -100.0% | -41.7% | -100.0% |
| alltime | all time | -41.7% | -100.0% | -41.7% | -100.0% |
MoonLake Immunotherapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.46 M(-41.7%) | $1.46 M(-24.7%) |
| Sep 2024 | - | $1.94 M(-4.3%) |
| Jun 2024 | - | $2.02 M(-14.2%) |
| Mar 2024 | - | $2.36 M(-5.7%) |
| Dec 2023 | $2.50 M | $2.50 M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $13.10 K(-75.3%) |
| Jun 2023 | - | $53.00 K(-41.8%) |
| Mar 2023 | - | $91.10 K(-29.4%) |
| Dec 2022 | $129.00 K(>+9900.0%) | $129.00 K(>+9900.0%) |
| Dec 2021 | $0.00 | $0.00 |
FAQ
- What is MoonLake Immunotherapeutics annual long term debt?
- What is the all time high annual long term debt for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual long term debt year-on-year change?
- What is MoonLake Immunotherapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly long term debt year-on-year change?
What is MoonLake Immunotherapeutics annual long term debt?
The current annual long term debt of MLTX is $1.46 M
What is the all time high annual long term debt for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual long term debt is $2.50 M
What is MoonLake Immunotherapeutics annual long term debt year-on-year change?
Over the past year, MLTX annual long term debt has changed by -$1.04 M (-41.70%)
What is MoonLake Immunotherapeutics quarterly long term debt?
The current quarterly long term debt of MLTX is $1.46 M
What is the all time high quarterly long term debt for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly long term debt is $2.50 M
What is MoonLake Immunotherapeutics quarterly long term debt year-on-year change?
Over the past year, MLTX quarterly long term debt has changed by -$478.10 K (-24.70%)